Job title: Scientist & Immuno-oncology Lead
Dr. Khattar is an immunologist at Takeda Pharmaceuticals, where he is leading efforts within Immuno-Oncology to leverage the immune-phenotypic features of anti-cancer agents and is engaged in designing next-generation approaches for cancer immunotherapy, particularly cell and gene therapies. Dr. Khattar’s previous research has focused on discovery of novel, antigen-specific immune therapies for cancer, autoimmunity and transplantation; involving modalities like CAR T-cells, personalized cancer vaccines, monoclonal antibodies and small molecule inhibitors. Prior to Takeda, he has held positions at Agenus Inc., Dana Farber Cancer Institute and Harvard Medical School. Dr. Khattar received his PhD in Immunology from the University of Toledo-Medical Center.
Utilizing & Translating CAR-T Cell Therapy to Solid Tumors 12:15 pm
• Discuss the challenges surrounding the clinical activity of CAR-T cell therapy in solid tumors • Exploring the degree of model translatability between preclinical studies and human CAR-T cell trials • Next-generation CART cell therapy approaches combining novel targets with endogenous immune modulationRead more
day: Day Two